Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease.

In an era of increasingly effective medications modifying the natural history of CF, identification of risk factors for early severe lung disease in CF remains relevant to permit interventions to prevent or postpone the time of future lung transplantation.